Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Lupus Stories

2014-04-10 12:27:11

America's largest lupus walk program takes place at South Street Seaport on Saturday, May 3 NEW YORK, April 10, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America will host its 2014 annual Walk To End Lupus Now(TM)( )event in New York City on Saturday, May 3 at the South Street Seaport. The largest lupus walk program in the country, Walk to End Lupus Now events are held in more than 60 cities, bringing together community members--lupus patients, friends, families,...

2014-04-04 23:38:31

Lupus Bible And Norton Protocol is developed by Julia Liu, who claims to teach people how to treat their lupus quickly and naturally. An overview on the website Vinaf.com shows if the program is worth buying. New York, NY (PRWEB) April 03, 2014 Lupus Bible And Norton Protocol is the latest program that provides people natural remedies, techniques, tips, and detailed instructions on how treat their lupus. In the program, people will discover all important information about lupus such as...

2014-04-03 08:27:41

Lupus Science & Medicine is launched to provide the latest lupus research and stimulate collaborative efforts to improving the lives of all people affected by lupus WASHINGTON, April 3, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America and BMJ announced today the launch and publication of the first scientific research articles in Lupus Science & Medicine(TM). Lupus Science & Medicine is a peer reviewed, Open Access, online journal that provides a central point for...

2014-03-31 16:27:30

HAYWARD, Calif., March 31, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced the appointment of Steven Engle to and the departure of Dr. James Healy, MD, PhD from its Board of Directors. "Steve's extensive experience in late-stage clinical development will be an invaluable resource to the Company," said Dr. Christopher S. Henney, Chairman of...

2014-03-27 12:27:48

New England Patriots defensive back Tavon Wilson serves as Walk Ambassador WASHINGTON, March 27, 2014 /PRNewswire-USNewswire/ -- Multi-talented entertainer and television personality Nick Cannon will serve as the Grand Marshal at the Walk to End Lupus Now(TM) event in Washington, D.C. on Saturday, April 19. Cannon will cut the opening ceremony ribbon and lead the more 4,000 walkers down Pennsylvania Avenue towards the Capitol, shedding light on the cruel mystery that is lupus....

2014-03-25 08:29:48

HERZLIYA, Israel, March 25, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, today announced the appointment of Daniel J. Wallace, MD and Murray Urowitz, MD, two experts in rheumatology, as consultants for the planned Phase II trial for the Company's hCDR1...

2014-03-20 12:32:58

LFA-REAL(TM) System is first of its kind tool to bring patients deeply into the development process WASHINGTON, March 20, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America announced today that it is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL((TM))(Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential...

2014-03-12 20:24:20

HAYWARD, Calif., March 12, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the fourth quarter and year ended December 31, 2013. Fourth Quarter and Fiscal Year 2013 Financial Results: Net loss for the fourth quarter and year ended December 31, 2013 was $9.2 million and $30.9 million, respectively. Operating expense for the year ended December 31, 2013 was $28.2 million as compared to $55.9 million for...

2014-03-11 23:33:04

Achieve is conducting a phase II, placebo-controlled, multi dose, 24-week clinical study to evaluate the efficacy and safety of a new autoimmune medication in participants living with systemic lupus erythematosus (SLE). Birmingham, Alabama (PRWEB) March 11, 2014 *To see if you qualify for this Lupus Clinical Trial in Birmingham, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There is no cost to participate, no...

2014-02-04 16:29:30

Lupus Research Organizations Welcome Big-Science Push to Drive New Therapies for Lupus Patients NEW YORK, Feb. 4, 2014 /PRNewswire/ -- The Alliance for Lupus Research (ALR) and the Lupus Research Institute (LRI) are proud to join the National Institutes of Health (NIH) in the Accelerating Medicines Partnership (AMP) launched today to speed new paths to treatment for lupus and autoimmune diseases. The new $230 million collaboration will harness the collective knowledge and resources...


Latest Lupus Reference Libraries

10_727908da8421f900a92d7a25ed6718ea2
2004-10-19 04:45:44

Lupus (the wolf) Constellation -- Lupus belongs to the constellations of the Southern Hemisphere roughly between DECL=-30 degrees and DECL=-55 degrees and RA=14h 20m and RA=16h 15m, respectively. It is located between Centaurus on the western and Scorpius and Norma on the eastern boundary. In the north Lupus borders on Libra, to the south it tops Circinus. As a part of the Milky Way stretches through Lupus it is an interesting part of the sky for simple stargazing with binoculars....

More Articles (1 articles) »